Literature DB >> 29512094

Two-dimensional versus three-dimensional transesophageal echocardiography in percutaneous left atrial appendage occlusion.

Witold Streb1, Katarzyna Mitręga2, Tomasz Podolecki2, Magdalena Szymała2, Anna Leopold-Jadczyk2, Tomasz Kukulski2, Zbigniew Kalarus2.   

Abstract

BACKGROUND: Real-time three-dimensional transesophageal echocardiography (RT3D TEE) enables better visualization of the left atrial appendage (LAA) and may be superior to real-time two-dimensional transesophageal echocardiography (RT2D TEE) for LAA occlusion (LAAO). The aim of this study was to assess inter- and intra-observer variability of RT2D TEE and RT3D TEE measurements of LAA, and to assess the accordance of RT2D TEE and RT3D TEE with appropriate occluder selection.
METHODS: Transesophageal echocardiography was performed in 40 patients during LAAO. RT2D TEE and RT3D TEE measurements of the ostium and landing zone were performed independently by two echocardiographers. The appropriate choice of occluder was confirmed with fluoroscopic criteria. After the procedures, RT2D TEE and RT3D TEE evaluation were repeated separately by the same echocardiographers.
RESULTS: The mean ostium diameters by RT2D TEE obtained by the two observers were 23.6 ± 4.2 vs. 24.8 ± 5.2 (p = 0.04), and the mean landing zone diameters were 17.7 ± 4.4 vs. 19.4 ± 3.9 (p < 0.01). In the case of RT3D TEE, the ostium diameters were 29.6 ± 5.3 vs. 29.4 ± 6.4 (p = not significant [NS]) and the landing zone diameters were 21.4 ± 3.8 vs. 21.6 ± 3.9 (p = NS). Intra-observer differences were absent in the case of RT3D TEE. The comparison of RT2D TEE vs. RT3D TEE analyses performed by the same echocardiographer revealed significant differences in the ostium and landing zone measurements (both p < 0.01). Agreement between the suggested device size was better for RT3D TEE (weighted kappa was 0.62 vs. 0.28, respectively).
CONCLUSIONS: The results obtained with RT3D TEE showed significantly larger dimensions of the ostium and the landing zone. RT3D TEE showed lesser inter- and intra-observer variability and better agreement with the implanted device.

Entities:  

Keywords:  Amplatzer Occluder; left atrial appendage occlusion; real-time two- and three-dimensional transesophageal echocardiography

Mesh:

Year:  2018        PMID: 29512094      PMCID: PMC8083037          DOI: 10.5603/CJ.a2018.0019

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  24 in total

1.  Real-time three-dimensional transesophageal echocardiography of the left atrial appendage: initial experience in the clinical setting.

Authors:  Sanjiv J Shah; Dianna M E Bardo; Lissa Sugeng; Lynn Weinert; Joseph A Lodato; Bradley P Knight; John J Lopez; Roberto M Lang
Journal:  J Am Soc Echocardiogr       Date:  2008-12       Impact factor: 5.251

2.  Twelve-month follow-up of left atrial appendage occlusion with Amplatzer Amulet.

Authors:  Caroline Kleinecke; Jai-Wun Park; Martin Gödde; Konstantin Zintl; Steffen Schnupp; Johannes Brachmann
Journal:  Cardiol J       Date:  2017-02-15       Impact factor: 2.737

3.  The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.

Authors:  Juan F Viles-Gonzalez; Saibal Kar; Pamela Douglas; Srinivas Dukkipati; Ted Feldman; Rodney Horton; David Holmes; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2012-03-06       Impact factor: 24.094

Review 4.  3D TEE during catheter-based interventions.

Authors:  Francesco Fulvio Faletra; Giovanni Pedrazzini; Elena Pasotti; Stefano Muzzarelli; Maria Cristina Dequarti; Romina Murzilli; Susanne Anna Schlossbauer; Iveta Petrova Slater; Tiziano Moccetti
Journal:  JACC Cardiovasc Imaging       Date:  2014-03

5.  Left atrial appendage closure with amplatzer septal occluder in patients with atrial fibrillation: CT-based morphologic considerations.

Authors:  Paul T Vaitkus; Dee Dee Wang; Mayra Guerrero; Adam Greenbaum; William O'Neill
Journal:  J Invasive Cardiol       Date:  2015-05       Impact factor: 2.022

6.  Left atrial appendage closure with the Amplatzer™ Cardiac Plug: Rationale for a higher degree of device oversizing at implantation.

Authors:  Joerg Neuzner; Thomas Dietze; Robert Paliege; Michael Möller; Giovanni Saeed; Rainer Gradaus
Journal:  Cardiol J       Date:  2014-10-09       Impact factor: 2.737

7.  Apixaban versus warfarin in patients with atrial fibrillation.

Authors:  Christopher B Granger; John H Alexander; John J V McMurray; Renato D Lopes; Elaine M Hylek; Michael Hanna; Hussein R Al-Khalidi; Jack Ansell; Dan Atar; Alvaro Avezum; M Cecilia Bahit; Rafael Diaz; J Donald Easton; Justin A Ezekowitz; Greg Flaker; David Garcia; Margarida Geraldes; Bernard J Gersh; Sergey Golitsyn; Shinya Goto; Antonio G Hermosillo; Stefan H Hohnloser; John Horowitz; Puneet Mohan; Petr Jansky; Basil S Lewis; Jose Luis Lopez-Sendon; Prem Pais; Alexander Parkhomenko; Freek W A Verheugt; Jun Zhu; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-08-27       Impact factor: 91.245

8.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

9.  Analysis of in vivo left atrial appendage morphology in patients with atrial fibrillation: a direct comparison of transesophageal echocardiography, planar cardiac CT, and segmented three-dimensional cardiac CT.

Authors:  Loren P Budge; Katherine M Shaffer; J Randall Moorman; Douglas E Lake; John D Ferguson; J Michael Mangrum
Journal:  J Interv Card Electrophysiol       Date:  2008-08-07       Impact factor: 1.900

10.  Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge.

Authors:  Dominique Deplanque; Didier Leys; Lucilla Parnetti; Reinhold Schmidt; Jose Ferro; Jacques de Reuck; Jean-Louis Mas; Virgilio Gallai
Journal:  Cerebrovasc Dis       Date:  2006-02-15       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.